Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01539447 · ClinicalTrials.gov registry record · Early Phase 1
Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy
A Early Phase 1 study of Heterotopic Ossification, sponsored by University of Utah.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT01539447: Completed Early Phase 1 study of Heterotopic Ossification, sponsored by University of Utah.
NCT01539447 is a Early Phase 1 study of Heterotopic Ossification that has completed, run by University of Utah. The registered enrollment target is 108 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (104% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01539447, a Early Phase 1 study of Heterotopic Ossification, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
In a brief summary the study would like to evaluate the effectiveness of Naproxen in preventing radiographically detected heterotopic ossification following hip arthroscopy for the treatment of femoroacetabular impingement.
Primary Outcome
The hypothesis is that there will be fewer instances of HO in the Naproxen group compared to the Placebo group.
Conditions Studied
Interventions
- DRUG placebo
- DRUG Naproxen
Study Locations (1)
Utah
- University of Utah Orthopedics Center - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2012-01 |
| Est. Completion | 2022-03-16 |
| Phase | Early Phase 1 |
What the finished NCT01539447 record still lists
NCT01539447 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (104% higher).
The record links to 1 condition, with Heterotopic Ossification appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT01539447 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT01539447 about?
NCT01539447 is a clinical study titled "Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy". In a brief summary the study would like to evaluate the effectiveness of Naproxen in preventing radiographically detected heterotopic ossification following hip arthroscopy for the treatment of femoroacetabular impingement.
What is the current status of trial NCT01539447?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 108 participants. The study started on 2012-01. Estimated completion is 2022-03-16.
What conditions does trial NCT01539447 study?
This clinical trial studies the following conditions: Heterotopic Ossification.
What interventions are being tested in trial NCT01539447?
The interventions under investigation include: placebo (DRUG), Naproxen (DRUG).
Who is sponsoring clinical trial NCT01539447?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01539447 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01539447's enrollment target sits among peer trials
108 170th of 2000 higher than 1,828 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia